2. Novi wulandari 11.01.01.078 3. Novita sari oktarina 11.01.01.079 4. Nuraini 11.01.01.080 5. Nurumatun mahmudah 11.01.01.081
A. Introduction Pharmacokinetics is the study of drug absorption, distribution, metabolism, and excretion .
Pharmacokinetics clinic is the science that applies the concepts and principles of pharmacokinetics in humans, aimed to draft a dose individually so as to optimize the therapeutic response of drugs while minimizing possible side effects.
B. Liver liver is has a multitude of important and complex functions, including to manufacture proteins, including albumin (to help maintain the volume of blood) and blood clotting factors; to synthesize, store, and process fats, including fatty acids (used for energy) and cholesterol.
general cause that make liver failure : Hepatitis B, Hepatitis C, Long term alcohol consumption, Cirrhosis, Hemochromatosis (an inherited disorder that causes the body to absorb and store too much iron) and Malnutrition Type of Liver failure Liver failure divided into two type : chronic and acute Symptoms of chronic liver failure is often fatty meals (grilled meat or fish, eggs, Smoking foods, butter),indigestion, increased body temperature (fever), the presence of lesions in the skin (dry and become wet eczema). Symptoms of liver failure Symptoms of heart failure include: 1. Aplastic anemia 2. Ascites 3. Edema or swelling under the skin 4. Encephalopathy 5. Enlarged liver and burning (pain) 6. Enlarged spleen 7. Changes in mental status or level of consciousness 8. Prone to bleeding Liver disease in humans encompasses a wide range of pathological disturbances that can lead to a reduction in liver blood flow, extrahepatic or intrahepatic shunting of blood,hepatocyte dysfunction, quantitative and qualitative changes in serum proteins, and changes in bile flow. Different forms of hepatic disease may produce different alterations in drug absorption, disposition and pharmacologic effect. The pharmacokinetic or pharmacodynamic consequences of a specific hepatic disease may differ between individuals or even within a single individual over time. Each of the major determinants of hepatic clearance and vascular architecture may be independently altered. Although there are numerous causes of hepatic injury, it appears that the hepatic response to injury is a limited one and that the functional consequences are determined more by the extent of the injury than by the cause. At this time there is no generally 7 available test that can be used to correlate changes in drug absorption and disposition with the degree of hepatic impairment. (Adedoyin A : 1988)
Effects of Liver Disease on Pharmacokinetics Therapy Therapyh liver failure : - Therapy without medication - Treatment with drugs ((aminoglycosides, Anti amoeba: dehydroemetine, Anti malaria: chloroquine diiodohydroxyquinoline, Anti-virus: Lamivudine) - Therapy with vaccination - Liver transplant therapy
Reperence Guidance for industry: Pharmacokinetics in patients with impaired renal function study design, data analysis, and impact on dosing and labeling. FDA, CDER,CBER,1998.http://www.fda.gov/cder/guidance/ind ex.html Adedoyin A, Selective effect of liver disease on the activities of specific metabolizing enzymes. Clin Pharmacol Ther 1998;64:8-17